Franklin Genomic Advancements ETF (HELX) — ETF Analysis on Winston

Key Facts

• Issuer: Franklin Templeton
• Category: Equity
• Asset Class: Equity
• Price: $39.22
• Expense Ratio: 50.00%
• Assets Under Management: $29M
• Number of Holdings: 63
• Inception Date: 2020-02-25
• Currency: USD

Winston Score

Franklin Genomic Advancements ETF has a Winston Score of 54 out of 100.

Performance

• 1-Year Return: 23.83%
• 3-Year Return: 13.94%
• 5-Year Return: -29.45%

Sector Breakdown

Basic Materials (N/A%), Healthcare (N/A%), Technology (N/A%)